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1. Introduction 
Although the effects of amine local anesthetics on 
electrical impulse transmission are well documented, 
the nature of the molecular interactions between these 
compounds and the cell membrane is still unclear [ 1,2]. 
Association of local anesthetics with lipid bilayers is 
believed to play at least some role particularly since 
many physical properties such as phase behavior and 
fluidity appear to be sensitive to anesthetics [3,4]. On 
the other hand specific interactions with membrane 
receptors involved in excitation have also been sug- 
gested [5]. 
Techniques such as NMR, ESR and fluorescence 
spectroscopy have been used to study the mechanism 
and site of interaction of local anesthetics with artifi- 
cial membranes [6-81. With the exception of recent 
NMRstudies on deuterated procaine [9], those meth- 
ods often rely on the perturbation of the environment 
by the anesthetic as detected by incorporated spin or 
fluorescent probes. Although such well-studied local 
anesthetics as procaine and tetracaine are weakly flu- 
orescent, their spectral properties are not suitable to 
allow their use directly as fluorescent probes particu- 
larly in natural membranes where spectral overlap 
between these molecules and protein tryptophans 
makes unambiguous interpretation exceedingly dif- 
ficult. Nevertheless, it would be of great value to be 
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able to directly measure the association of anesthetic 
molecules with biological membranes and to probe 
the nature of the interaction with both lipid and pro- 
tein domains. 
We report here the synthesis and spectral proper- 
ties of a fluorescent procaine analogue, N,Ndiethyl- 
aminoethyl(2-N-methyl)benzoate-HCl (I) (DANB). 
Studies on the binding of this molecule with phospho- 
lipid vesicles suggest hat DANB can be an extremely 
useful probe to mimic anesthetic interactions with 
bilayers. 
2. Experimental 
N,N-Diethylaminoethyl(2~N-methyl)benzoate-HCl 
was synthesized by the general method in [lo]. 
N-methylisatoic anhydride (Molecular Probes) (0.75 g) 
and 0.05 g NaOH was dissolved in 3 ml spectral grade 
N,Ndiethylethanolamine and heated for 90 min at 
60°C under a positive pressure of Nz. The free amine 
obtained from this reaction was converted to the 
hydrochloride salt by acidification of the ethereal 
solution with concentrated HCl. The salt was recrys- 
tallized from hot propanol to give the desired product 
in 70% yield (m.p. 150.0-I 50.5”C). Thin-layer chro- 
matography in chloroform-methanol (3:7) indicated 
a single fluorescent species. Structure and purity was 
confirmed by IR, ‘H-NMR analysis and elemental 
analysis. 
Phospholipid vesicles were prepared by sonicating 
(Braunsonlc, 1510; 10 min at 70 W) 10 mg egg phos- 
phatidylcholine/ml (Sigma) in either Hz0 or 15 mM 
Tris-HCl (pH 7.4). The opalescent solution was centri- 
fuged for 1 h at 100 000 X g to remove particulate 
material. 
Fluorescence measurements were made using either 
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a SLM 4800 spectrofluorometer or a Perkin-Elmer 
MPF44B spectrofluorometer equipped with a DCSU 
corrected spectra unit. Quantum yields were deter- 
mined using quinine sulfate in 1 N HzS04 as a reference 
(quantum yield, 0.55 [ 111). Samples were excited at 
366 nm at an absorbance ranging from 0.01-0.02. 
All phospholipid samples were equilibrated for 5-10 
min at 24°C in the sample compartment prior to mea- 
surement. Total fluorescence intensities were obtained 
by integrating the area under the spectrum from 
370-550 nm using a computer spectral analysis pro- 
gram. 
3. Results 
Fig.1 shows the uncorrected emission and excitation 
spectra of DANB in Hz0 and in 100% ethanol. The 
emission maximum is blue shifted from 443 nm in 
Hz0 to 423 nm in ethanol with a corresponding 
enhancement of 4.5-fold in fluorescence intensity. 
The emission spectra of DANB in the presence of 
egg phosphatidylcholine vesicles at pH 7.4 is shown 
in fig.2. Interaction with vesicles is accompanied by 
an enhancement of fluorescence intensity as well as 
a 7 nm blue shift in emission maximum. This is 
expected if some fraction of the probe were transferred 
from the polar aqueous environment to a more non- 
polar lipid domain. Since DANB exists mainly in its 
protonated form at pH 7.4, its partitioning into the 
phospholipid bilayer would be relatively low. How- 
ever, increasing the pH of the solution and therefore 
the relative concentration of the more non-polar free 
base, should lead to enhanced binding and a corre- 
sponding increase in fluorescence intensity. The pH 
dependence of the relative intensity (fig3A) shows 
that this is indeed the case. In addition, this enhance- 
ment is accompanied by a pronounced shift to ldwer 
wavelengths (fig3B). In the absence of phospholipid 
vesicles, there is no pHdependent wavelength shift 
and a considerably smaller change in fluorescence 
intensity. 
A more detailed study of the interaction of the 
probe with phospholipid vesicles at pH 9.0 is shown 
in fig.4. Increasing [lipid] from 0.05-3.0 mg/ml leads 
to a progressive increase in fluorescence intensity and 
increasing blue shift in wavelength of emission. A plot 
of wavelength shift as a function of [lipid] at 
12.5 X 10” M DANB (fig.5) shows that the wavelength 
reaches a minimum between 3-3.5 mg lipid/ml. In 
Wavelength (nm) 
Fig.1. Excitation and emission spectra of DANB. Excitation 
spectra (I) in H,O (--) and ethanol (--_) were recorded at 
an emission wavelength of 445 nm. Corresponding emission 
spectra (II) were recorded at an excitation wavelength of
350 nm. [DANB] = 5 X lo-’ M. 
450 500 550 
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Fig.2. Emission spectra of DANB in the absence (--) and 
presence (-) of 3.0 mg phosphatidylchoIine/ml in 0.015 M 
Tris-HCl (pH 7.4). [DANB] = 12.5 X 1O-6 M. 
F-H PH 
Fig.3. pH dependence of the relative fluorescence intensity 
(A) and the maximum emission wavelength (B) of DANB in 
3.0 mg phosphatidylcholine/ml and 0.015 M Tris-HCl. 
[DANB] = 12.5 X lo-’ M. 
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Fig.4. Emission spectra of DANB in phosphatidylcholine 
vesicles in 0.015 M Tri-HCl (pH 9.0). Phospholipid concen- 
trations in increasing order of intensity were: 0.00; 0.05,0.10, 
0.20,0.40,0.60,0.80, I .OO, I .25, 2.00,2.50 and 3.00 mg/ml. 
[DANB] = 12.5 X IO+ M. 
addition, the relative intensity also approaches maxi- 
mum levels at this lipid concentration (not shown) and 
one can therefore assume that under these conditions, 
the probe is totally bound and that the spectral char- 
acteristics exhibited at this pH reflect the nature of 
the binding site. 
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Fig.5. The dependence of the maximum emission wavelength 
of DANB on the phospholipid concentration. Experimental 
conditions were as in tig.4. 
To determine the environment of the binding site 
of the probe, the effects of solvent on the emission 
spectral parameters were studied. As expected, large 
changes in the fluorescence quantum yield and emis- 
sion maximum are observed with changes in the eth- 
anol composition of ethanol/H*0 mixtures (table 1). 
Linear correlations are found between emission maxi- 
mum and two commonly used polarity scales, one 
reflecting the dielectric constant of the solvent mix- 
ture [ 121 and the other an empirical polarity scale 
Z introduced in [ 131. The Z polariry scale (fig.6) gave 
a better fit with a correlation coefficient of 0.995 
Table 1 
Solvent dependence of the fluorescence properties of DANB 
% Ethanol Emission’ Quantum Dielectric 
(ethanol/H,O) max. (nm) yield (6) constant (D)a 
Zb 
100 425 0.51 24 79.6 
90 429 0.55 29 82.5 
80 430 0.56 35 84.8 
70 433 0.57 40 86.4 
60 436 0.52 47 87.9 
50 438 0.49 52 89.2 
40 439 0.42 58 90.5 
30 441 0.31 64 91.6 
20 443 0.22 69 92.6 
10 444 0.16 74 93.6 
0 445 0.12 80 94.6 
aFrom [12];bfrom [13] 
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Fig.6. The dependence of the maximum emission wavelength 
of DANB on the Z value of the solvent in e~ano~~H~0 mix- 
tures. [ DANB] = 5 X 1 0e6 M. 
compared to 0.987 for the dependence on dielectric 
constant (not shown). A better correlation between 
the emission parameters of an~nonap~alene sdfonic 
acid (ANS) and the Z polarity scale was reported [ 121. 
From fig.5, the limiting emission maximum is 423 nm 
(uncorrected) or 429 nm (corrected), a value which 
corresponds to the emission in 90% ethanol and to a 
2 value of 82 and a dielectric constant of -29 (table 1). 
The corres~o~d~gv~ue for the fluorescence quantum 
yield in phospho~pid vesicles should therefore be 
0.55 compared to 0.12 in HzO. 
An alternative method for determining the quan- 
tum yield of fully bound probe involves measuring 
the extrapolated maximum relative intensity from 
double reciprocal plots. When the data in fig.4 was 
expressed in this form plotting reciprocal intensity 
against reciprocal [lipid], at 12.5 X 10” M DANB 
the extrapolated intercept at the ordinate can be taken 
to reflect fully bound probe to give a relative quan- 
tum yield of 0.42, a value significantly lower than that 
obtained from the solvent studies. There are several 
possible explanations for this discrepancy: 
(i) Double reciprocal plots tend to underestimate 
the true maximum fluorescence intensity [ 141. 
(ii) Any quenching of bound fluorophore in the 
phosphoiipid vesicles would tend to decrease 
the estimated quantum yield but should have 
little effect on the wavelength of emission. 
The latter parameter therefore provides a more mean- 
ingful measure of the local environment of the probe. 
4. Discussion 
The use of fluorescent anesthetic derivatives to 
model the behavior oflocal amine anesthetics provides 
a powerful technique to study the mechanism of action 
of anesthetics at the molecular level. The fluorescent 
derivative we have described here is a highly suitable 
probe since it is theN-methyl ortho-isomer of procaine. 
The or&-isomers of both procaine and tetracaine have 
anesthetic activity; the ortho-isomer of procaine is 
even more active than procaine itself [IS]. Because of 
its close structural resemblance to procaine, it is also 
unlikely to cause anomolous perturbation of the bilayer 
structure that may occur with other larger heterocyclic 
aromatic fluorescent probes such as pyrene or anthra- 
cene. 
The fluorescence characteristics of this derivative 
also make it highly suitable as a molecular probe. There 
is minimal overlap between excitation and emission 
spectra thus allowing one to study probe interactions 
even in highly scattering solutions. The excitation band 
is well removed from those of tryptophan and tyrosine 
residues and perhaps more interestingly, the large over- 
lap between tryptophan emission and DANB excita- 
tion bands makes this probe potentially useful in 
studying energy-transfer phenomena in biological mem- 
branes The high sensitivity of the probe to solvent 
polarity also allows one to quantitate the binding of 
the mofecule to both natural and artificial membranes 
and to obtain information on the nature of the binding 
site(s). 
Studies on the fluorescence of DANB in egg phos- 
phatidylcholine vesicles, suggest hat the binding envi- 
ronment has a dielectric constant of -29 and a Z 
polarity value of 82. These values are within the range 
of those reported for the polarity of the hydrocarbon- 
water interface of detergent micelles (Z = 82-85) [ 161 
and of egg phosphatidylcholine bilayers (D = 28) [ 171, 
suggesting that the aromatic ring of the anesthetic 
molecule is situated at or near the lipid-water inter- 
face even at pH 9 .O . 
The physiolo~cal effects of amine anesthetics are 
known to be pH-dependent [ 181. Although the charged 
form of the anesthetic is the biologically active species 
blocking action potentials from the inner surface of 
the nerve, it may be the uncharged form that trans- 
verses the bilayer [18]. This conclusion is consistent 
with the observation that the partition coefficient of 
procaine and tetracaine in phosphatidylcholinejwater 
dispersions increases with increasing pH [9]. Our stud- 
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ies on the pH dependence of DANB fluorescence in 
phospholipid bilayers also support this conclusion. 
Using deuterium-labelled anesthetics evidence has 
been provided for multiple binding sites for charged 
and uncharged forms of local anesthetics [9]. Other 
studies also suggest polar and non-polar interactions 
between these molecules and phospholipid bilayers 
[7 1. The steady-state fluorescence spectral character- 
istics of DANB in egg phosphatidylcholine vesicles 
can not be interpreted in terms of multiple binding 
domains although at present this possibility can not 
be excluded. We are currently attempting to deter- 
mine the orientation of DANB within the bilayer by 
the use oflocalized spin quenchers [ 191. These studies 
should provide valuable insights into the distribution 
of anesthetics within biological membranes. 
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